{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:24Z","timestamp":1786982724177,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40121-025-01274-4","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:35:40Z","timestamp":1764171340000},"page":"297-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Growth in Anaerobic Bottles is an Independent Predictor of Mortality in Pseudomonas aeruginosa Bloodstream Infections"],"prefix":"10.1007","volume":"15","author":[{"given":"Daniel N.","family":"Marco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Morata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pitart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bodro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"del R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Garcia-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Duminy-Luppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Canela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Brey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Hern\u00e1ndez-Meneses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Cuervo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateu","family":"Espasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Climent","family":"Casals-Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Mensa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-354X","authenticated-orcid":false,"given":"Sabina","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"1274_CR1","doi-asserted-by":"publisher","unstructured":"Pont S, Janet-Maitre M, Faudry E, Cretin F, Attr\u00e9e I. Molecular mechanisms involved in Pseudomonas aeruginosa bacteremia. In: Filloux A, Ramos JL, editors. Pseudomonas aeruginosa. Advances in Experimental Medicine and Biology, vol 1386. Cham: Springer; 2022; p. 325\u2013345. https:\/\/doi.org\/10.1007\/978-3-031-08491-1_12.","DOI":"10.1007\/978-3-031-08491-1_12"},{"issue":"6","key":"1274_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106196","volume":"56","author":"E del Barrio-Tofi\u00f1o","year":"2020","unstructured":"del Barrio-Tofi\u00f1o E, L\u00f3pez-Causap\u00e9 C, Oliver A. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired \u03b2-lactamases: 2020 update. Int J Antimicrob Agents. 2020;56(6):106196. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106196.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"1274_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/S10096-021-04342-Y","volume":"41","author":"K Teelucksingh","year":"2022","unstructured":"Teelucksingh K, Shaw E. Clinical characteristics, appropriateness of empiric antibiotic therapy, and outcome of Pseudomonas aeruginosa bacteremia across multiple community hospitals. Eur J Clin Microbiol Infect Dis. 2022;41(1):53\u201362. https:\/\/doi.org\/10.1007\/S10096-021-04342-Y.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"1274_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2334-14-161","volume":"14","author":"YJ Kim","year":"2014","unstructured":"Kim YJ, Jun YH, Kim YR, et al. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy. BMC Infect Dis. 2014;14(1):161. https:\/\/doi.org\/10.1186\/1471-2334-14-161.","journal-title":"BMC Infect Dis"},{"key":"1274_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02671-16","author":"JT Thaden","year":"2017","unstructured":"Thaden JT, Park LP, Maskarinec SA, Ruffin F, Fowler VG, Van Duin D. Results from a 13-year prospective cohort study show increased mortality associated with bloodstream infections caused by Pseudomonas aeruginosa compared to other bacteria. Antimicrob Agents Chemother. 2017. https:\/\/doi.org\/10.1128\/AAC.02671-16.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"1274_CR6","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1128\/AAC.00750-12","volume":"56","author":"L Morata","year":"2012","unstructured":"Morata L, Cobos-Trigueros N, Mart\u0301inez JA, et al. Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother. 2012;56(9):4833\u20137. https:\/\/doi.org\/10.1128\/AAC.00750-12.","journal-title":"Antimicrob Agents Chemother"},{"key":"1274_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx315","author":"M Ripa","year":"2017","unstructured":"Ripa M, Rodr\u00edguez-N\u00fa\u00f1ez O, Cardozo C, et al. Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis. J Antimicrob Chemother. 2017. https:\/\/doi.org\/10.1093\/jac\/dkx315.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"1274_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/CID\/CIU866","volume":"60","author":"C Pea","year":"2015","unstructured":"Pea C, Cabot G, G\u00f3mez-Zorrilla S, et al. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections. Clin Infect Dis. 2015;60(4):539\u201348. https:\/\/doi.org\/10.1093\/CID\/CIU866.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1274_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/S13054-025-05292-Z","volume":"29","author":"DN Marco","year":"2025","unstructured":"Marco DN, Brey M, Anguera S, et al. Time to positivity as a predictor of catheter-related bacteremia and mortality in adults with Pseudomonas aeruginosa bloodstream infection. Crit Care. 2025;29(1):63. https:\/\/doi.org\/10.1186\/S13054-025-05292-Z.","journal-title":"Crit Care"},{"key":"1274_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-595-8_9","author":"DL Paterson","year":"2009","unstructured":"Paterson DL, Kim BN. Pseudomonas aeruginosa. Antimicrob Drug Resist. 2009. https:\/\/doi.org\/10.1007\/978-1-60327-595-8_9.","journal-title":"Antimicrob Drug Resist"},{"key":"1274_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/405191","author":"M Toyofuku","year":"2012","unstructured":"Toyofuku M, Uchiyama H, Nomura N. Social behaviours under anaerobic conditions in Pseudomonas aeruginosa. Int J Microbiol. 2012. https:\/\/doi.org\/10.1155\/2012\/405191.","journal-title":"Int J Microbiol"},{"issue":"3","key":"1274_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1172\/JCI13870","volume":"109","author":"D Worlitzsch","year":"2002","unstructured":"Worlitzsch D, Tarran R, Ulrich M, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest. 2002;109(3):317\u201325. https:\/\/doi.org\/10.1172\/JCI13870.","journal-title":"J Clin Invest"},{"issue":"7","key":"1274_CR13","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1128\/IAI.02014-05","volume":"74","author":"MJ Filiatrault","year":"2006","unstructured":"Filiatrault MJ, Picardo KF, Ngai H, Passador L, Iglewski BH. Identification of Pseudomonas aeruginosa genes involved in virulence and anaerobic growth. Infect Immun. 2006;74(7):4237\u201345. https:\/\/doi.org\/10.1128\/IAI.02014-05.","journal-title":"Infect Immun"},{"issue":"11","key":"1274_CR14","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1099\/jmm.0.45727-0","volume":"53","author":"DA Enoch","year":"2004","unstructured":"Enoch DA, Simpson AJ, Kibbler CC. Predictive value of isolating Pseudomonas aeruginosa from aerobic and anaerobic blood culture bottles. J Med Microbiol. 2004;53(11):1151\u20134. https:\/\/doi.org\/10.1099\/jmm.0.45727-0.","journal-title":"J Med Microbiol"},{"key":"1274_CR15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-10-200211190-00007","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002. https:\/\/doi.org\/10.7326\/0003-4819-137-10-200211190-00007.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1274_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/J.MEDIN.2017.09.012","volume":"42","author":"F Chaves","year":"2018","unstructured":"Chaves F, Garnacho-Montero J, del Pozo JL, et al. Diagnosis and treatment of catheter-related bloodstream infection: clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC). Med Intensiva. 2018;42(1):5\u201336. https:\/\/doi.org\/10.1016\/J.MEDIN.2017.09.012.","journal-title":"Med Intensiva"},{"issue":"11","key":"1274_CR17","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181. https:\/\/doi.org\/10.1007\/s00134-021-06506-y.","journal-title":"Intensive Care Med"},{"issue":"3","key":"1274_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/J.1469-0691.2011.03570.X","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/J.1469-0691.2011.03570.X.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1274_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/clinids\/24.3.403","volume":"24","author":"FR Cockerill","year":"1997","unstructured":"Cockerill FR, Hughes JG, Vetter EA, et al. Analysis of 281,797 consecutive blood cultures performed over an eight- year period: trends in microorganisms isolated and the value of anaerobic culture of blood. Clin Infect Dis. 1997;24(3):403. https:\/\/doi.org\/10.1093\/clinids\/24.3.403.","journal-title":"Clin Infect Dis"},{"issue":"7964","key":"1274_CR20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41586-023-06111-7","volume":"618","author":"P Cao","year":"2023","unstructured":"Cao P, Fleming D, Moustafa DA, et al. A Pseudomonas aeruginosa small RNA regulates chronic and acute infection. Nature. 2023;618(7964):358\u201364. https:\/\/doi.org\/10.1038\/s41586-023-06111-7.","journal-title":"Nature"},{"issue":"8","key":"1274_CR21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/J.IJMM.2010.08.007","volume":"300","author":"M Schobert","year":"2010","unstructured":"Schobert M, Jahn D. Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung. Int J Med Microbiol. 2010;300(8):549\u201356. https:\/\/doi.org\/10.1016\/J.IJMM.2010.08.007.","journal-title":"Int J Med Microbiol"},{"issue":"4","key":"1274_CR22","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1128\/JB.184.4.1140-1154.2002","volume":"184","author":"K Sauer","year":"2002","unstructured":"Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol. 2002;184(4):1140\u201354. https:\/\/doi.org\/10.1128\/JB.184.4.1140-1154.2002.","journal-title":"J Bacteriol"},{"issue":"10","key":"1274_CR23","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41579-022-00767-0","volume":"20","author":"K Sauer","year":"2022","unstructured":"Sauer K, Stoodley P, Goeres DM, et al. The biofilm life cycle: expanding the conceptual model of biofilm formation. Nat Rev Microbiol. 2022;20(10):608\u201320. https:\/\/doi.org\/10.1038\/s41579-022-00767-0.","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"1274_CR24","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1128\/AAC.04636-14","volume":"59","author":"S G\u00f3mez-Zorrilla","year":"2015","unstructured":"G\u00f3mez-Zorrilla S, Camoez M, Tubau F, et al. Prospective observational study of prior rectal colonization status as a predictor for subsequent development of Pseudomonas aeruginosa clinical infections. Antimicrob Agents Chemother. 2015;59(9):5213\u20139. https:\/\/doi.org\/10.1128\/AAC.04636-14.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"1274_CR25","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1128\/IAI.00822-09","volume":"77","author":"NE Van Alst","year":"2009","unstructured":"Van Alst NE, Wellington M, Clark VL, Haidaris CG, Iglewski BH. Nitrite reductase NirS is required for type\u00a0III secretion system expression and virulence in the human monocyte cell line THP-1 by Pseudomonas aeruginosa. Infect Immun. 2009;77(10):4446. https:\/\/doi.org\/10.1128\/IAI.00822-09.","journal-title":"Infect Immun"},{"issue":"10","key":"1274_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/S41579-022-00682-4","volume":"20","author":"O Ciofu","year":"2022","unstructured":"Ciofu O, Moser C, Jensen P\u00d8, H\u00f8iby N. Tolerance and resistance of microbial biofilms. Nat Rev Microbiol. 2022;20(10):621\u201335. https:\/\/doi.org\/10.1038\/S41579-022-00682-4.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"1274_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/CID\/CIAC784","volume":"76","author":"OR Albin","year":"2023","unstructured":"Albin OR, Kaye KS, Mccreary EK, Pogue JM. Less is more? Antibiotic treatment duration in Pseudomonas aeruginosa ventilator-associated pneumonia. Clin Infect Dis. 2023;76(4):745\u20139. https:\/\/doi.org\/10.1093\/CID\/CIAC784.","journal-title":"Clin Infect Dis"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01274-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-025-01274-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01274-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T11:27:51Z","timestamp":1767871671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-025-01274-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1274"],"URL":"https:\/\/doi.org\/10.1007\/s40121-025-01274-4","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Daniel N. Marco, Laura Morata, Cristina Pitart, Marta Bodro, Ana del R\u00edo, Carolina Garcia-Vidal, Diego Duminy-Luppy, Jos\u00e9 Canela, Maria Brey, Marta Hern\u00e1ndez-Meneses, Guillermo Cuervo, Mateu Espasa, Climent Casals-Pascual, Felipe Garc\u00eda, Josep Mensa, Jos\u00e9 Antonio Mart\u00ednez and Sabina Herrera have nothing to disclose. Alex Soriano is an Editorial Board member of\n                      Infectious Diseases and Therapy\n                      . Alex Soriano was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki of 1964 and was approved by the institutional review board and approved by the Ethics Committee of Hospital Clinic of Barcelona, Spain (Approval No. HCB\/2024\/0934). Written informed consent was waived because of the non-interventional retrospective design and nature of the data. Publication was approved by the ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}